Corient Private Wealth’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-38,940	Closed	-$3.54M	–	2169
2023 Q1	$3.54M	Buy	+38,940	New	+$3.54M	0.01%	685